Premium
Systemic therapy for advanced adrenal cancer
Author(s) -
Dreicer Robert
Publication year - 2012
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23078
Subject(s) - medicine , systemic therapy , mitotane , chemotherapy , neoplasm , adrenocortical carcinoma , cancer , systemic administration , oncology , pathology , breast cancer , microbiology and biotechnology , in vivo , biology
Abstract The systemic management of advanced adrenal cancer remains a major therapeutic dilemma as it is both highly resistant to systemic agents and very rare epithelial neoplasm making clinical investigation a significant challenge. The role of mitotane, systemic chemotherapy and novel targeted agents are reviewed. J. Surg. Oncol. 2012; 106:643–646. © 2012 Wiley Periodicals, Inc.